Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SCD1 inhibitor-4
Cat. No.:
OB0225LY-0226
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
SCD1 inhibitor-4 is a selective fatty acid synthase 1 (SCD1) inhibitor that regulates lipid metabolism.
Synonym:
1295541-87-5; 5-Methyl-N-(1-methyl-1H-pyrazol-3-yl)-1-(3-(trifluoromethyl)benzyl)-1H-imidazole-4-carboxamide; 5-Methyl-N-(1-methylpyrazol-3-yl)-1-[[3-(trifluoromethyl)phenyl]methyl]imidazole-4-carboxamide; 5-Methyl-N-(1-methylpyrazol-3-yl)-1-{[3-(trifluoromethyl)phenyl]methyl}imidazole-4-carboxamide
CAS No.:
1295541-87-5
Compound CID:
51346908
Formula:
C17H16F3N5O
Formula Weight:
363.34
Specification
Relative Density:
1.36 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SCD1 inhibitor-4 can be used to study insulin sensitivity or play an important role in obesity-related research.
Library Information
Targets:
Stearoyl-CoA desaturase (SCD) family
Receptors:
SCD1
Pathways:
Metabolism
Plate Number:
AOCL-3
Plate Location:
g10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
90 mg/mL; 247.70 mM
